प्लान में उपलब्ध है
एक साथ कई कंपनियों का विश्लेषण करना चाहते हैं? सशुल्क प्लान में आप अधिकतम 5 शेयरों की साथ-साथ तुलना कर सकते हैं।
साइन अप करें
CMP
vs
S
S&P/ASX 300
CMP
पिछले 12 महीने में CMP ने S&P/ASX 300 से कमजोर प्रदर्शन किया। इसका रिटर्न -31% रहा, जबकि S&P/ASX 300 में 3% की गिरावट आई।
शेयरों का प्रदर्शन
CMP vs S&P/ASX 300
प्रदर्शन में अंतर
CMP vs S&P/ASX 300
वर्ष के अनुसार प्रदर्शन
CMP vs S&P/ASX 300
शेयर के रिटर्न की तुलना उसके बेंचमार्क सूचकांक और प्रतिस्पर्धियों से करें। समय के साथ उसके सापेक्ष प्रदर्शन को समझें।
Compumedics Ltd
एक नज़र में
Compumedics makes medical devices and software used to monitor the brain, sleep, and breathing. Its main products include systems for sleep studies, neurological testing, and research recordings, along with the sensors, consumables, and analysis software that go with them. Hospitals, sleep clinics, researchers, and specialist doctors use these tools to diagnose conditions like sleep apnea and to study brain activity and other physiological signals. The company sells its equipment upfront and also earns recurring revenue from software, service, support, and consumable supplies. That mix matters because the installed base of devices often leads to follow-on sales of parts, upgrades, and maintenance. Its business sits in a niche part of healthcare where accurate signal measurement and reliable data handling are more important than flashy consumer branding. What makes Compumedics different is that it is not a broad hospital supplier; it is focused on highly specialized recording systems for sleep and neurodiagnostics. It sits between medical equipment makers and the clinicians who need precise test data, so its value comes from combining hardware, software, and domain-specific expertise into one system.